Indian Journal of Gynecologic Oncology, published by SPRINGER INDIA, is a distinguished platform dedicated to the rigorous dissemination of research and advancements in the fields of gynecologic oncology. With an ISSN of 2363-8397 and E-ISSN of 2363-8400, the journal aims to bridge the gap between clinical practice and research in obstetrics and gynecology, while also addressing pivotal issues in oncology. Operating from its headquarters in New Delhi, India, the journal has been active since 2016 and is recognized within the academic community, achieving a Category Quartile of Q3 in Obstetrics and Gynecology and Q4 in Oncology as of 2023. Although currently not an open-access journal, it offers extensive access options for subscribing institutions and professionals. With its commitment to high-quality peer-reviewed content, the journal serves as a vital resource for researchers, clinicians, and students dedicated to advancing knowledge and improving patient outcomes in gynecologic cancers.

The European Journal of Surgical Oncology (EJSO), published by Elsevier Science Ltd, stands as a leading international journal dedicated to the field of surgical oncology. With an ISSN of 0748-7983 and an E-ISSN of 1532-2157, EJSO has been a key resource for researchers and practitioners since its inception in 1985, covering a wide spectrum of topics in advanced surgical techniques, oncology practices, and multidisciplinary approaches to cancer treatment. The journal boasts impressive rankings, being classified in the Q1 quartile for Medicine (Miscellaneous) and Surgery, and Q2 in Oncology for 2023, reflecting its high impact within the scientific community, with a Scopus ranking of #36/551 in Medicine and Surgery, placing it in the 93rd percentile. Although it does not currently offer Open Access options, EJSO remains committed to advancing the field through reliable research and innovative surgical methodologies. Its ongoing contributions are invaluable for those engaged in the continuous improvement of cancer treatment and management.

Taiwanese Journal of Obstetrics & Gynecology, published by Elsevier Taiwan, stands as a leading platform in the field of obstetrics and gynecology, fostering academic discourse and innovative research since its inception in 2004. With an impact factor that places it in the Q2 category of its field, it ranks #84 out of 209 journals in Obstetrics and Gynecology according to Scopus, indicating a significant reputation within the medical community. This open access journal ensures wide dissemination of research findings, allowing professionals, researchers, and students alike to stay updated with the latest advancements and practices. The journal's focus on publishing high-quality, peer-reviewed articles covers a broad range of topics within the field, making it an essential resource for those interested in women's health issues, clinical practices, and medical advancements in Taiwan and beyond. With its commitment to excellence, the Taiwanese Journal of Obstetrics & Gynecology invites contributions that enhance the understanding and management of obstetric and gynecological care.

Gynecology and Minimally Invasive Therapy (GMIT) is a distinguished open-access journal published by Wolters Kluwer Medknow Publications, focused on advancing the field of obstetrics and gynecology through innovative research and insights into minimally invasive techniques. With an ISSN of 2213-3070 and E-ISSN 2213-3089, GMIT has established itself as a prominent platform for researchers and clinicians alike, facilitating the dissemination of pivotal findings since its inception in 2012. The journal currently ranks in the Q3 category for Obstetrics and Gynecology in 2023, with a Scopus ranking of #120/209, placing it in the 42nd percentile within its field. Based in Mumbai, India, it has embraced open access since 2016, promoting the wide availability of groundbreaking research to enhance clinical practices and improve patient outcomes. GMIT aims to foster knowledge sharing and interdisciplinary collaboration, vital for professionals in the rapidly evolving landscape of gynecological care.

Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.

Journal of Gastrointestinal Cancer, published by SPRINGER, stands as a crucial resource in the fields of Gastroenterology and Oncology. With an ISSN of 1941-6628 and E-ISSN of 1941-6636, this journal has been committed to advancing the understanding and treatment of gastrointestinal cancers since its inception in 2007 and is poised to continue until 2024. The journal is recognized in the Q3 quartiles for both Gastroenterology and Oncology as of 2023, reflecting its relevance and contribution to these vital areas of medical research. Despite not being an open-access journal, it offers printed and online subscription options for access, ensuring that valuable research reaches the hands of practitioners, researchers, and students alike. With a focus on disseminating original research, reviews, and case studies, the Journal of Gastrointestinal Cancer plays a pivotal role in fostering ongoing education and discovery in the fight against cancer, promoting better patient outcomes worldwide. The journal is also indexed in Scopus, with notable rankings in the 50th and 45th percentiles for Gastroenterology and Oncology, respectively, further underscoring its scientific merit and credibility in the academic community.

Gynecologic Oncology, an esteemed journal published by Academic Press Inc Elsevier Science, stands at the forefront of research in the domains of Obstetrics and Gynecology and Oncology. With an exceptional track record dating from 1972 to 2024, this journal has established itself as a vital resource for scholars and practitioners alike, boasting a remarkable Q1 ranking in both fields as of 2023. Gynecologic Oncology not only ranks #13 out of 209 in Obstetrics and Gynecology and #72 out of 404 in Oncology but also operates within the top percentiles of academic influence, with a 94th percentile in Obstetrics and Gynecology and an 82nd percentile in Oncology on Scopus. Although the journal does not currently offer open access, it remains crucial for disseminating original research, reviews, and advances in the management and treatment of gynecological cancers. Researchers and health professionals will find this journal indispensable for staying informed on the latest advancements and breakthroughs in this vital area of medicine, fostering a deeper understanding and potentially transforming patient care practices.

Translational Lung Cancer Research is a leading journal dedicated to advancing the field of oncology, particularly focusing on groundbreaking discoveries in lung cancer treatment and management. Published by AME Publishing Company, this journal boasts an impressive Q1 classification in the 2023 Oncology category, reflecting its significant contribution to the scientific community, with an outstanding Scopus rank of #92 out of 404 in Medicine _ Oncology, placing it in the 77th percentile. With its commitment to open access, the journal fosters international collaboration and accessibility, making cutting-edge research available to a wide audience. The scope of Translational Lung Cancer Research encompasses clinical trials, experimental studies, and translational research that bridge the gap between laboratory findings and clinical applications. Researchers, professionals, and students seeking to keep abreast of the latest developments in lung cancer research will find invaluable insights within its pages. For further information, please contact at FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG.

The Journal of Minimally Invasive Gynecology, published by Elsevier Science Inc, stands as a premier platform dedicated to advancing the field of obstetrics and gynecology with a specific focus on minimally invasive techniques. With an impressive impact factor that reflects its significance within the field, this journal is ranked in the Q1 category for Obstetrics and Gynecology, placing it among the top 25% of journals in its domain. Since its inception in 2005, it has consistently provided high-quality research, clinical insights, and innovative findings that are crucial for professionals, researchers, and students eager to stay abreast of the latest advancements. The journal operates on a hybrid open access model, ensuring that valuable knowledge is widely disseminated while promoting academic exchange across its converged years leading up to 2024. As it continues to publish cutting-edge studies, the Journal of Minimally Invasive Gynecology remains a vital resource for those committed to improving patient outcomes and enhancing surgical practices through minimally invasive methodologies.

The Indian Journal of Surgical Oncology, published by SPRINGER INDIA, is a vital source of scholarly research and discourse in the fields of oncology and surgery. Since its inception in 2010, the journal has been dedicated to advancing the science and practice of surgical oncology, providing a platform for researchers, clinicians, and educators to disseminate their findings and insights. With an increasing impact factor, the journal currently ranks in the Q4 category in Oncology and Q3 category in Surgery, reflecting its growing influence in the academic community. The journal maintains a focus on high-quality research, clinical studies, and innovative surgical techniques, fostering knowledge exchange among professionals in India and beyond. Although an open access option is not provided, the journal remains an essential repository of information for anyone engaged in the rapidly evolving fields of surgical oncology. For access to groundbreaking research and updates in the discipline, the Indian Journal of Surgical Oncology continues to be an indispensable resource.